Intas Pharma, Henlius receive positive CHMP opinion for Hetronifly in European markets as first line treatment for adult patients with Extensive-Stage Small Cell Lung Cancer Ruchika Sharma26 Sept 2024 11:00 AM ISTAhmedabad: Intas Pharmaceuticals Limited has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...
Intas Pharma to commercialise Serplulimab in India Ruchika Sharma30 Oct 2023 3:29 PM ISTSerplulimab will be commercialised by Intas in India and by its subsidiary, Accord Healthcare Ltd, in Europe.
Intas Pharma marketing authorization application for proposed biosimilar of Stelara accepted by EMA Ruchika Sharma15 July 2023 11:00 AM ISTDMB-3115 is a proposed biosimilar to Stelara which is a blockbuster drug developed by Janssen Biotech Inc. for plaque psoriasis, psoriatic arthritis,...
Piramal Critical Care ropes in Jeffrey Hampton as President, COO Ruchika Sharma6 Jun 2023 5:28 PM ISTMumbai: Piramal Pharma Limited’s Piramal Critical Care (PCC) business has announced the appointment of Jeffrey Hampton as President & Chief...
Myovant Sciences, Accord Healthcare ink pact for prostate cancer treatment Relugolix Ruchika Sharma10 May 2022 10:15 AM ISTORGOVYX (relugolix, 120 mg) is indicated in Europe for the treatment of adult patients with advanced hormone-sensitive prostate cancer.
Pharma firms slapped USD 360 million fine after steroid price hikes over 10000 percent Ruchika Sharma16 July 2021 11:30 AM ISTCMA has fined Actavis UK, Auden Mckenzie, Allergan, Accord Healthcare, Intas, Waymade Plc, Amdipharm, Advanz Pharma and some entities of...
